查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404817

醫院感染診斷市場規模、佔有率和趨勢分析報告：按測試類型、感染類型、產品類型、地區和細分市場預測，2023-2030年

Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Conventional), By Infection Type (UTI, Pneumonia), By Product (Consumables), By Type, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10個工作天內

價格

醫院感染診斷市場的成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球醫院感染診斷市場預計將達到 71.5 億美元。

預計 2023 年至 2030 年，全球醫院感染診斷市場將以 7.2% 的複合年成長率健康成長。促進市場成長的因素包括 MRSA 和艱難梭菌等抗藥性病原體的增加、人口高齡化以及能夠在短時間內提供準確可靠結果的技術先進產品的開拓。

產業成長的另一個因素是低收入和中等收入國家對HAI診斷的需求不斷增加，進一步推動了對HAI診斷市場的需求。醫療工作者意識的提高和政府提案的措施進一步推動了該行業的成長。然而，已開發國家醫院感染流行率的下降可能會阻礙產業成長。

HAI 診斷市場根據感染類型和測試類型進行細分。感染類型分為尿道感染（UTI）、血流感染（BSI）、手術部位感染（SSI）、肺炎等。截至 2015 年， 尿道感染領域預計將佔據最大佔有率，而肺炎 HAI 診斷預計將從 2015 年到 2022 年以最高複合年成長率成長。 HAI 診斷產業進一步細分為分子測試和其他體外測試。儘管分子診斷領域的佔有率較低，但預計未來幾年將出現良好的成長。

醫院感染診斷市場報告亮點

  • 2022年，消耗品領域在醫院感染診斷市場中佔據最大收入佔有率，為63.5%，由於醫院感染發病率上升，預計在預測期內將以7.7%的最快複合年成長率擴張。
  • 2022 年，血液檢測領域佔最大收益佔有率，達到 65.8%，預計在預測期內將以 7.08% 的最快複合年成長率發展。
  • 歐洲主導市場，2022 年收益佔有率最大，為 34.3%。這是由於疾病負擔高、基礎設施可用性高、醫療保健支出不斷增加、技術進步迅速、政府積極主動、患者意識增強以及主要企業的存在。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章醫院感染診斷市場的變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 醫院感染診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章醫院感染診斷市場：檢測類型估算及趨勢分析

  • 醫院感染診斷市場：重點
  • 醫院感染診斷市場：2022 年和 2030 年測試類型趨勢和市場佔有率分析
  • 傳統的
    • 2018-2030 年傳統市場估計與預測
  • 分子
    • 2018-2030 年分子市場估計與預測

第5章醫院感染診斷市場：感染類型估計與趨勢分析

  • 醫院感染診斷市場：重點
  • 醫院感染診斷市場：2022 年和 2030 年感染類型趨勢和市場佔有率分析
  • 尿道感染
    • 2018-2030 年尿道感染市場估計與預測
  • 肺炎
    • 2018-2030 年肺炎市場估計與預測
  • 手術部位感染
    • 2018-2030 年手術部位感染市場估計與預測
  • 血流感染疾病
    • 2018-2030 年血流感染疾病市場估計與預測
  • 其他
    • 2018-2030 年其他感染疾病市場估計與預測

第6章 醫院感染診斷市場：產品估算及趨勢分析

  • 醫院感染診斷市場：重點
  • 醫院感染診斷市場：2022 年和 2030 年產品趨勢和市場佔有率分析
  • 消耗品
    • 2018-2030 年消耗品市場估計與預測
  • 裝置
    • 2018-2030 年設備市場估計與預測

第7章 醫院感染診斷市場：類型估計與趨勢分析

  • 醫院感染診斷市場：重點
  • 醫院感染診斷市場：2022 年和 2030 年類型變動和市場佔有率分析
  • 驗血
    • 2018-2030 年血液檢測市場估計與預測
  • 尿液檢查
    • 2018-2030 年尿液檢查市場估計與預測

第8章醫院感染診斷市場：區域估算及趨勢分析

  • 區域展望
  • 按地區分類的醫院感染診斷市場：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • BIOMERIEUX
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthcare Private Limited
    • BD (Becton, Dickinson and Company)
    • Hologic, Inc.
    • Meridian Bioscience, Inc.
    • QIAGEN
    • Thermo Fisher Scientific Inc.
    • Bioscience, Inc.
Product Code: 978-1-68038-783-4

Hospital Acquired Infections Diagnostics Market Growth & Trends:

The global hospital acquired infections diagnostics market is expected to reach USD 7.15 billion by 2030, according to a new report by Grand View Research, Inc. The global hospital acquired infections diagnostics market is projected to grow at a healthy CAGR of 7.2% during the period of 2023 to 2030. Factors attributing to the growth of the market are increase in the number of drug-resistant pathogens such as MRSA and C. difficile, advancing age of geriatric population, and development of technologically advanced products that offer accurate and reliable results with low turnaround time.

Another factor contributing to industry growth is the increasing demand of HAI diagnostics from middle and low income countries, further driving demand for HAI diagnostic market. Increasing awareness among healthcare workers and proposed government initiatives are further supporting industry growth. However, decline in the prevalence rate of nosocomial infections in the developed countries is likely to hinder industry growth.

The HAI diagnostics market is categorized on the basis of infection type and test type. On the basis of infection type, the market is segmented into Urinary Tract Infection (UTI), Blood Stream Infection (BSI), Surgical Site Infection (SSI), pneumonia, and others. As of 2015, the urinary tract infection segment was estimated to account for the largest share, whereas the pneumonia HAI diagnostics is projected to grow at the highest CAGR during the period of 2015 to 2022.The HAI diagnostics industry is further segmented into molecular tests and other in-vitro tests. Though the molecular diagnostics segment is estimated to constitute a low share, it is anticipated to witness a lucrative growth in the next few years.

Hospital Acquired Infections Diagnostics Market Report Highlights:

  • The consumables segment held the largest revenue share of 63.5% in the hospital acquired infections diagnostics market in 2022 and is expected to expand at the fastest CAGR of 7.7% over the forecast period, owing to the rising incidence of HAIs.
  • The blood tests segment accounted for the largest revenue share of 65.8% in 2022 and is expected to advance at the fastest CAGR of 7.08% during the forecast period.
  • Europe dominated the market and accounted for the largest revenue share of 34.3% in 2022, owing to the high disease burden, the availability of infrastructure, increased healthcare expenditure, rapid technological advancements, proactive government initiatives, rise in patient awareness, and the presence of major players.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test Type
    • 1.1.2. Infection Type
    • 1.1.3. Product
    • 1.1.4. Type
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type outlook
    • 2.2.2. Infection Type outlook
    • 2.2.3. Product outlook
    • 2.2.4. Type outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hospitals Acquired Infections Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Hospitals Acquired Infections Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Hospitals Acquired Infections Diagnostics Market: Test Type Estimates & Trend Analysis

  • 4.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 4.2. Hospital Acquired Infections Diagnostics Market: Test Type Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Conventional
    • 4.3.1. Conventional market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Molecular
    • 4.4.1. Molecular market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hospital Acquired Infections Diagnostics Market: Infection Type Estimates & Trend Analysis

  • 5.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 5.2. Hospital Acquired Infections Diagnostics Market: Infection Type Movement & Market Share Analysis, 2022 & 2030
  • 5.3. UTI
    • 5.3.1. UTI market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Pneumonia
    • 5.4.1. Pneumonia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Surgical Site Infection
    • 5.5.1. Surgical site infection market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Blood Stream Infections
    • 5.6.1. Blood stream infections market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others infections market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hospital Acquired Infections Diagnostics Market: Product Estimates & Trend Analysis

  • 6.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 6.2. Hospital Acquired Infections Diagnostics Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Consumables
    • 6.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Instruments
    • 6.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Hospital Acquired Infections Diagnostics Market: Type Estimates & Trend Analysis

  • 7.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 7.2. Hospital Acquired Infections Diagnostics Market: Type Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Blood Tests
    • 7.3.1. Blood tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Urinalysis
    • 7.4.1. Urinalysis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Hospital Acquired Infections Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Hospitals Acquired Infections Diagnostics Market by Region: Key Takeaways
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Denmark
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Norway
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. BIOMERIEUX
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Abbott
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. F. Hoffmann-La Roche Ltd.
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Siemens Healthcare Private Limited
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. BD (Becton, Dickinson and Company)
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Hologic, Inc.
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Meridian Bioscience, Inc.
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. QIAGEN
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Thermo Fisher Scientific Inc.
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Bioscience, Inc.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America hospital acquired infections diagnostics market, by infection Type, 2018 - 2030 (USD Million)
  • Table 4 North America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 6 North America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 8 U.S. hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 9 U.S. hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 12 Canada hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 13 Canada hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 15 Europe hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 16 Europe hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 17 Europe hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 18 Europe hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 19 Europe hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 20 UK hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 21 UK hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 22 UK hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 23 UK hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 25 Germany hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 26 Germany hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 28 France hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 29 France hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 30 France hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 31 France hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Italy hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 33 Italy hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 34 Italy hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 35 Italy hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 37 Spain hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 38 Spain hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 39 Spain hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 40 Denmark hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 41 Denmark hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 42 Denmark hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 43 Denmark hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 44 Sweden hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 45 Sweden hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 46 Sweden hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 47 Sweden hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 48 Norway hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 49 Norway hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 50 Norway hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 51 Norway hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 57 Japan hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 58 Japan hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 59 Japan hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 60 Japan hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 61 China hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 62 China hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 63 China hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 64 China hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 65 India hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 66 India hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 67 India hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 68 India hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 69 Australia hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 70 Australia hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 71 Australia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 72 Australia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 73 Thailand hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 74 Thailand hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 75 Thailand hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 76 Thailand hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 77 South Korea hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 78 South Korea hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 79 South Korea hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Korea hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 81 Latin America hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 82 Latin America hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 83 Latin America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 84 Latin America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 85 Latin America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 87 Brazil hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 88 Brazil hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 89 Brazil hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 90 Mexico hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 91 Mexico hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 92 Mexico hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 93 Mexico hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 94 Argentina hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 95 Argentina hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 96 Argentina hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 97 Mexico hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 103 South Africa hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 104 South Africa hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 105 South Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 106 South Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 111 UAE hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 112 UAE hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 113 UAE hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 114 UAE hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 115 Kuwait hospital acquired infections diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait hospital acquired infections diagnostics market, by infection type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 118 Kuwait hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Microneedle Instruments systems: market outlook
  • Fig. 8 Hospital Acquired Infections Diagnostics competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Hospital acquired infections diagnostics market driver impact
  • Fig. 13 Hospital acquired infections diagnostics market restraint impact
  • Fig. 14 Hospital acquired infections diagnostics market strategic initiatives analysis
  • Fig. 15 Hospital acquired infections diagnostics market: Test type movement analysis
  • Fig. 16 Hospital acquired infections diagnostics market: Test type outlook and key takeaways
  • Fig. 17 Molecular market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Conventional market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Hospital acquired infections diagnostics market: Infection type movement analysis
  • Fig. 20 Hospital acquired infections diagnostics market: Infection type outlook and key takeaways
  • Fig. 21 UTI market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Pneumonia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Surgical site infection market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Blood stream infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Hospital acquired infections diagnostics market: Product movement analysis
  • Fig. 27 Hospital acquired infections diagnostics market: Product outlook and key takeaways
  • Fig. 28 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Hospital acquired infections diagnostics market: Type movement analysis
  • Fig. 31 Hospital Acquired Infections Diagnostics market: Type outlook and key takeaways
  • Fig. 32 Blood tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Urinalysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Global hospital acquired infections diagnostics market: Regional movement analysis
  • Fig. 35 Global hospital acquired infections diagnostics market: Regional outlook and key takeaways
  • Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)